TARA Protara: Bozor kapitallashuvining balans qiymatiga nisbati

Protara (TARA) - korporativ logo

GURU.Markets platformasidagi Protara Therapeutics (TARA) uchun ushbu narxlar grafigi, strategiyasi kamyob onkologik patologiyalarga qarshi maxsus dori vositalarini ishlab chiqishga asoslangan aktivning narxlar dinamikasini namoyish etadi, bu esa sug'urta fondlari tomonidan qo'llab-quvvatlangan holda 0.87 darajasidagi rentabellikni ta'minlaydi. Ishlab chiqarish AI va robotlashtirilgan sintez tizimlarining joriy etilishi orqali optimallashtirildi, operatsiyalarning gumanitar profili esa biznesni geosiyosiy risklar va sanksiyalardan himoya qiladi.

Protara Therapeutics (TARA) - Bozor kapitallashuvining balans qiymatiga nisbati 04.07.2022dan 27.10.2026gacha

TARA (Protara Therapeutics Inc): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Protara Therapeutics|TARA - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Protara|TARA - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Protara Therapeutics|TARA - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati protaratx.com|TARA - Biznesning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Protara Therapeutics|TARA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Protara|TARA - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati Protara
Fundamental baholash:TARA (Protara Therapeutics)
Protara Therapeutics Inc tayyor mahsulotlari

Ushbu ko'rsatkich Protara Therapeutics (TARA) kompaniyasining joriy bozor qiymati va uning sof aktivlari o'rtasidagi nisbatni aks ettirib, biznesning haddan tashqari qimmat yoki past baholanganligini baholash imkonini beradi. Kompaniyaga tegishli P/B ko'rsatkichi o'zgarishlarini tahlil qilish orqali investor baholashning spekulyativ tabiatini aniqlashi mumkin, bu esa ayniqsa autsorsing modeliga ega bo'lgan sog'liqni saqlash giganti uchun juda muhimdir, chunki shaxsiy inshootlarning yo'qligi kapitalizatsiyani moddiy aktivlardan ko'ra intellektual mulkka bog'liq qiladi.

Asosiy raqobatchilar

ONC: Bozor kapitallashuvining balans qiymatiga nisbati|halozyme.com (HALO) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati RVMD|Kapitallashuvning sof aktivlarga nisbati Ascentage Pharma Group International|Bozor kapitallashuvining balans qiymatiga nisbati CGON|Bozor kapitallashuvining balans qiymatiga nisbati URGN (UroGen Pharma Corp)|BCAX - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati personalis.com PSNL|ERAS: Bozor kapitallashuvining balans qiymatiga nisbati|DCTH - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati YMAB|AURA (Aura Corp) - Bozor qiymatining balans qiymatiga koeffitsiyenti|CADL - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati accuray.com (ARAY)|SELLAS Life Sciences (SLS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Actuate Therapeutics Inc. (ACTU)|Citius Oncology, Inc - Bozor kapitallashuvining balans qiymatiga nisbati|HURA - Kapitallashuvning sof aktivlarga nisbati|Fate Therapeutics, Inc. - Kapitallashuvning sof aktivlarga nisbati|WHWK: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati tscan.com TCRX|Champions Oncology, Inc. (CSBR) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati XBIT (XBiotech Inc)|Bozor qiymatining balans qiymatiga koeffitsiyenti CVM|OSTX - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi RADX (Radiopharm Theranostics Ltd)|Bozor qiymatining balans qiymatiga nisbati Artiva Biotherapeutics|Adlai Nortye Ltd - Balans qiymatiga nisbatan bozor qiymati|VERU (Veru Pharma) - Bozor qiymatining balans qiymatiga nisbati|Tempest Therapeutics Corp (TPST) - Bozor qiymatining balans qiymatiga koeffitsiyenti|XLO - Kapitallashuvning sof aktivlarga nisbati|Renovaro (RENB) - Bozor kapitallashuvining balans qiymatiga multiplikatori|MURA (Mural Oncology PLC) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati KAPA|OnKure Therapeutics Inc (OKUR) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati w2.cytomed.sg (GDTC)|Bozor kapitallashuvining balans qiymatiga nisbati CRIS (Curis)|APLM - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Tharimmune (THAR)|Advanced Biomed Inc (ADVB) - Balans qiymatiga nisbatan bozor qiymati|GNPX - Kapitallashuvning sof aktivlarga nisbati|Calidi Biotherapeutics, Inc. (CLDI) - Bozor kapitallashuvining balans qiymatiga multiplikatori|SBFM - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Xenetic Bio|Salarius Pharmaceuticals, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti PPBT (Purple Biotech Ltd)|Bozor qiymatining balans qiymatiga nisbati American Oncology Network, Inc.|Balans qiymatiga nisbatan bozor qiymati BeiGene Ltd BGNE|Checkpoint Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|ELEV: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati icadmed.com (ICAD)|Ikena Oncology (IKNA) - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati NTBL (Notable Labs Inc.)|Bozor qiymatining balans qiymatiga koeffitsiyenti Viracta (VIRX)|Kapitallashuvning sof aktivlarga nisbati MOR|Bozor kapitallashuvining balans qiymatiga nisbati nayabiosciences.com NAYA|Kapitallashuvning sof aktivlarga nisbati Ascentage Pharma (AAPGV)